BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
-14.54%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$613M
AUM Growth
-$108M
(-15%)
Cap. Flow
+$5.9M
Cap. Flow
% of AUM
0.96%
Top 10 Holdings %
Top 10 Hldgs %
30.19%
Holding
150
New
11
Increased
47
Reduced
31
Closed
17
Top Buys
| 1 |
Supernus Pharmaceuticals
SUPN
|
$4.49M |
| 2 |
Amgen
AMGN
|
$3.2M |
| 3 |
Larimar Therapeutics
LRMR
|
$3.2M |
| 4 |
INSY
Insys Therapeutics, Inc.
INSY
|
$2.56M |
| 5 |
Incyte
INCY
|
$2.21M |
Top Sells
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.46M |
| 2 |
Cardinal Health
CAH
|
$3.3M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$3.09M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$2.98M |
| 5 |
Alkermes
ALKS
|
$2.96M |
Sector Composition
| 1 | Healthcare | 91.86% |
| 2 | Financials | 0.95% |
| 3 | Industrials | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Thermo Fisher Scientific
TMO
$183B
| $2.45M | 0.4% |
20,000
+7,000
| +54% | +$856K |
|
|
HTWR
77
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $2.35M | 0.38% |
45,000
+23,000
| +105% | +$1.2M |
|
78
Teleflex
TFX
$5.57B
| $2.31M | 0.38% |
18,557
-11,443
| -38% | -$1.42M |
|
79
Novavax
NVAX
$1.2B
| $2.3M | 0.37% |
16,250
-9,750
| -38% | -$1.38M |
|
|
MDVN
80
DELISTED
MEDIVATION, INC.
MDVN
| $2.24M | 0.36% |
52,600
-70,000
| -57% | -$2.98M |
|
81
Healthcare Services Group
HCSG
$1.14B
| $2.19M | 0.36% |
65,000
| – | – |
|
|
NUVA
82
DELISTED
NuVasive, Inc.
NUVA
| $2.17M | 0.35% |
45,000
| – | – |
|
|
QGENF
83
DELISTED
QIAGEN NV
QGENF
| $2.06M | 0.34% |
80,000
+20,000
| +33% | +$516K |
|
|
UBIO
84
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
| $2.04M | 0.33% |
+7,000
| New | +$2.04M |
|
85
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.95M | 0.32% |
59,000
-42,000
| -42% | -$1.39M |
|
|
SGEN
86
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.85M | 0.3% |
48,000
+8,000
| +20% | +$309K |
|
87
Globus Medical
GMED
$7.94B
| $1.81M | 0.3% |
87,700
| – | – |
|
88
MacroGenics
MGNX
$121M
| $1.78M | 0.29% |
83,000
+2,000
| +2% | +$42.8K |
|
|
BLUE
89
DELISTED
bluebird bio
BLUE
| $1.75M | 0.29% |
1,583
+39
| +3% | +$43.2K |
|
|
WCG
90
DELISTED
Wellcare Health Plans, Inc.
WCG
| $1.72M | 0.28% |
20,000
| – | – |
|
91
Celldex Therapeutics
CLDX
$1.57B
| $1.69M | 0.28% |
10,667
+5,734
| +116% | +$906K |
|
92
Baxter International
BAX
$12.1B
| $1.64M | 0.27% |
+50,000
| New | +$1.64M |
|
93
Inovio Pharmaceuticals
INO
$144M
| $1.53M | 0.25% |
22,083
+5,416
| +32% | +$376K |
|
94
AbbVie
ABBV
$374B
| $1.47M | 0.24% |
27,000
| – | – |
|
95
DaVita
DVA
$9.72B
| $1.45M | 0.24% |
20,000
-6,000
| -23% | -$434K |
|
|
ICPT
96
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.44M | 0.24% |
8,700
+1,200
| +16% | +$199K |
|
|
ALDR
97
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.41M | 0.23% |
+43,000
| New | +$1.41M |
|
|
JUNO
98
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.34M | 0.22% |
33,000
-15,000
| -31% | -$610K |
|
99
AngioDynamics
ANGO
$432M
| $1.32M | 0.22% |
100,000
| – | – |
|
100
Myriad Genetics
MYGN
$633M
| $1.24M | 0.2% |
33,000
-5,000
| -13% | -$187K |
|